Mandate

Vinge advises Cinven’s portfolio company Partner in Pet Food in connection with its acquisition of the Doggy

Vinge advises Cinven’s portfolio company Partner in Pet Food, a leading European pet food manufacturer, in connection with its acquisition of the Doggy Group (“Doggy”).

Doggy is a leading Swedish pet food producer and distribution with well-known brands such as Doggy, Mjau and Bozita. The acquisition will complement Partner in Pet Food's product range, geographical markets and distribution channels.

The transaction is conditional upon customary approvals by competition authorities.

Vinge’s team mainly consisted of partner Christina Kokko and associates Carl Sander, Hannah Kajlinger and Jonathan Riddersholm (M&A), Christoffer Nordin and Ellinor Wargenbrant (Corporate Commercial), Olof Löfvenberg (Environment & Permits), Axel Jansson and Felix Möller (Banking & Finance), Lisa Ullman and Ebba Svenburg (Employment), Karl-Hugo Engdahl (IT), Xandra Ståhlberg and Lisa Malmborg (Antitrust) and VDR-assistant Carl Bruneheim.

 

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026